PAA
CRSP icon

Peregrine Asset Advisers’s CRISPR Therapeutics CRSP Stock Holding History

Peregrine Asset Advisers’s Portfolio CRSP Stock Details CRSP Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,647
Closed -$267K – 140
2021
Q2 		$267K Buy
+1,647
New +$267K 0.12% 102